Vivani Medical (VANI) Competitors $1.06 +0.01 (+0.95%) Closing price 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI vs. STIM, NVRO, RCEL, NYXH, INGN, ELMD, DRTS, PDEX, LNSR, and BWAYShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Neuronetics (STIM), Nevro (NVRO), AVITA Medical (RCEL), Nyxoah (NYXH), Inogen (INGN), Electromed (ELMD), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), LENSAR (LNSR), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Neuronetics Nevro AVITA Medical Nyxoah Inogen Electromed Alpha Tau Medical Pro-Dex LENSAR BrainsWay Vivani Medical (NASDAQ:VANI) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends. Is VANI or STIM more profitable? Vivani Medical has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. Vivani Medical's return on equity of -102.42% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -102.42% -49.21% Neuronetics -50.09%-141.24%-32.77% Do insiders and institutionals believe in VANI or STIM? 6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 44.3% of Vivani Medical shares are held by insiders. Comparatively, 9.8% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, VANI or STIM? Vivani Medical has a beta of 2.76, indicating that its share price is 176% more volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Does the MarketBeat Community believe in VANI or STIM? Neuronetics received 123 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 68.62% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformVivani MedicalOutperform Votes6100.00% Underperform VotesNo VotesNeuroneticsOutperform Votes12968.62% Underperform Votes5931.38% Which has higher valuation & earnings, VANI or STIM? Vivani Medical has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$25.65M-$0.44-2.41Neuronetics$74.89M3.30-$30.19M-$1.37-2.74 Does the media prefer VANI or STIM? In the previous week, Vivani Medical had 9 more articles in the media than Neuronetics. MarketBeat recorded 10 mentions for Vivani Medical and 1 mentions for Neuronetics. Vivani Medical's average media sentiment score of 0.90 beat Neuronetics' score of 0.44 indicating that Vivani Medical is being referred to more favorably in the media. Company Overall Sentiment Vivani Medical Positive Neuronetics Neutral Do analysts rate VANI or STIM? Vivani Medical currently has a consensus price target of $4.00, indicating a potential upside of 277.36%. Neuronetics has a consensus price target of $5.50, indicating a potential upside of 46.28%. Given Vivani Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Vivani Medical is more favorable than Neuronetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Neuronetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryVivani Medical beats Neuronetics on 12 of the 17 factors compared between the two stocks. Remove Ads Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.79M$3.10B$5.28B$7.34BDividend YieldN/A1.78%5.11%4.31%P/E Ratio-2.3614.8521.6917.75Price / SalesN/A43.53378.4897.65Price / CashN/A44.0938.1534.64Price / Book2.593.326.433.98Net Income-$25.65M$94.03M$3.20B$247.33M7 Day Performance4.95%1.47%5.08%4.44%1 Month Performance-3.64%-10.43%-9.65%-7.72%1 Year Performance-42.39%-21.04%10.92%1.30% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.7978 of 5 stars$1.06+1.0%$4.00+277.4%-45.3%$62.79MN/A-2.3620Analyst ForecastShort Interest ↑STIMNeuronetics1.7713 of 5 stars$3.55+0.6%$5.50+54.9%-6.7%$232.33M$74.89M-2.89180Short Interest ↑Gap DownNVRONevro0.8635 of 5 stars$5.85+0.1%$6.43+9.9%-53.9%$224.32M$408.52M-3.091,215Analyst ForecastRCELAVITA Medical1.317 of 5 stars$7.76+3.5%$17.25+122.3%-7.0%$203.45M$64.25M-3.25130NYXHNyxoah2.0679 of 5 stars$5.71-6.1%$14.75+158.3%-35.3%$194.48M$4.52M-3.05110Short Interest ↑Gap DownINGNInogen3.0273 of 5 stars$7.09+0.7%$7.00-1.3%-0.7%$190.63M$335.71M-3.151,030Short Interest ↓News CoverageHigh Trading VolumeELMDElectromed1.1528 of 5 stars$22.16-1.0%$38.00+71.5%+56.3%$189.62M$59.63M29.55160Positive NewsDRTSAlpha Tau Medical2.6738 of 5 stars$2.45-2.8%$8.00+226.5%-7.3%$172.43MN/A-5.7080Short Interest ↓Gap DownHigh Trading VolumePDEXPro-Dex1.5265 of 5 stars$52.87+3.9%$52.00-1.6%+229.7%$172.41M$61.00M26.30140Short Interest ↑Positive NewsGap DownHigh Trading VolumeLNSRLENSAR1.1013 of 5 stars$13.76-0.6%$15.00+9.0%+355.3%$162.22M$53.49M-9.42110Short Interest ↓High Trading VolumeBWAYBrainsWay3.649 of 5 stars$8.61-2.7%$13.17+52.9%+63.4%$162.10M$41.02M86.11120Short Interest ↓Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies STIM Competitors NVRO Competitors RCEL Competitors NYXH Competitors INGN Competitors ELMD Competitors DRTS Competitors PDEX Competitors LNSR Competitors BWAY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VANI) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
